Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 538

1.

Predictive validation and forecasts of short-term changes in healthcare expenditure associated with changes in smoking behavior in the United States.

Lightwood J, Anderson S, Glantz SA.

PLoS One. 2020 Jan 16;15(1):e0227493. doi: 10.1371/journal.pone.0227493. eCollection 2020.

2.

Transferring Racial/Ethnic Marketing Strategies From Tobacco to Food Corporations: Philip Morris and Kraft General Foods.

Nguyen KH, Glantz SA, Palmer CN, Schmidt LA.

Am J Public Health. 2020 Jan 16:e1-e8. doi: 10.2105/AJPH.2019.305482. [Epub ahead of print]

PMID:
31944842
3.

The Association Between Secondhand Smoke Exposure and Survival for Patients with Heart Failure.

Psotka MA, Rushakoff J, Glantz SA, De Marco T, Fleischmann KE.

J Card Fail. 2020 Jan 8. pii: S1071-9164(19)30620-7. doi: 10.1016/j.cardfail.2019.12.008. [Epub ahead of print]

PMID:
31926217
4.

Smokeless tobacco industry's brand stretching in India.

Yadav A, Ling P, Glantz S.

Tob Control. 2020 Jan 9. pii: tobaccocontrol-2019-055382. doi: 10.1136/tobaccocontrol-2019-055382. [Epub ahead of print] No abstract available.

PMID:
31919227
5.

Net Effect of Young Adult Dual Combusted Cigarette and E-Cigarette Users' Anticipated Responses to Hypothetical E-Cigarette Marketing Restrictions.

Glantz SA.

Subst Use Misuse. 2020 Jan 6:1-3. doi: 10.1080/10826084.2019.1710209. [Epub ahead of print]

PMID:
31902287
6.

Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis.

Bhatta DN, Glantz SA.

Am J Prev Med. 2019 Dec 11. pii: S0749-3797(19)30391-5. doi: 10.1016/j.amepre.2019.07.028. [Epub ahead of print]

PMID:
31859175
7.

The Grassroots of Grass: Cannabis Legalization Ballot Initiative Campaign Contributions and Outcomes, 2004-2016.

Orenstein DG, Glantz SA.

J Health Polit Policy Law. 2019 Oct 15. pii: 7893579. doi: 10.1215/03616878-7893579. [Epub ahead of print]

PMID:
31675092
8.

Tobacco Use in Top-Grossing Movies - United States, 2010-2018.

Tynan MA, Polansky JR, Driscoll D, Garcia C, Glantz SA.

MMWR Morb Mortal Wkly Rep. 2019 Nov 1;68(43):974-978. doi: 10.15585/mmwr.mm6843a4.

9.

Adding Data From 2015 Strengthens the Association Between E-Cigarette Use and Myocardial Infarction.

Alzahrani T, Glantz SA.

Am J Prev Med. 2019 Oct;57(4):569-571. doi: 10.1016/j.amepre.2019.03.008. No abstract available.

PMID:
31542134
10.

Uneven Access to Smoke-Free Laws and Policies and Its Effect on Health Equity in the United States: 2000-2019.

Hafez AY, Gonzalez M, Kulik MC, Vijayaraghavan M, Glantz SA.

Am J Public Health. 2019 Nov;109(11):1568-1575. doi: 10.2105/AJPH.2019.305289. Epub 2019 Sep 19.

PMID:
31536405
11.

Exceeding FCTC obligations: Nepal overcoming tobacco industry interference to enact a comprehensive tobacco control policy.

Bhatta DN, Bialous S, Crosbie E, Glantz S.

Nicotine Tob Res. 2019 Sep 19. pii: ntz177. doi: 10.1093/ntr/ntz177. [Epub ahead of print]

PMID:
31535694
12.

In defense of sugar: a critical analysis of rhetorical strategies used in The Sugar Association's award-winning 1976 public relations campaign.

Kearns CE, Glantz SA, Apollonio DE.

BMC Public Health. 2019 Aug 22;19(1):1150. doi: 10.1186/s12889-019-7401-1.

13.

Tobacco control in Nepal during a time of government turmoil (1960-2006).

Bhatta D, Crosbie E, Bialous S, Glantz S.

Tob Control. 2019 Jul 30. pii: tobaccocontrol-2019-055066. doi: 10.1136/tobaccocontrol-2019-055066. [Epub ahead of print]

PMID:
31363061
14.

San Francisco Voters End the Sale of Flavored Tobacco Products.

Yang YT, Glantz S.

Ann Intern Med. 2019 Jun 18;170(12):907-908. doi: 10.7326/L19-0154. No abstract available.

PMID:
31207627
15.

Fostering bioinformatics education through skill development of professors: Big Genomic Data Skills Training for Professors.

Zhan YA, Wray CG, Namburi S, Glantz ST, Laubenbacher R, Chuang JH.

PLoS Comput Biol. 2019 Jun 13;15(6):e1007026. doi: 10.1371/journal.pcbi.1007026. eCollection 2019 Jun.

16.

Civic Engagement in California Cannabis Policy Development.

Bowling C, Glantz SA.

J Psychoactive Drugs. 2019 Nov-Dec;51(5):391-399. doi: 10.1080/02791072.2019.1627444. Epub 2019 Jun 12.

PMID:
31187690
17.

Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health.

Bhatta DN, Glantz SA.

J Am Heart Assoc. 2019 Jun 18;8(12):e012317. doi: 10.1161/JAHA.119.012317. Epub 2019 Jun 5. Erratum in: J Am Heart Assoc. 2019 Nov 5;8(21):e002313.

18.

Synthetic cell-like membrane interfaces for probing dynamic protein-lipid interactions.

Glantz ST, Berlew EE, Chow BY.

Methods Enzymol. 2019;622:249-270. doi: 10.1016/bs.mie.2019.02.015. Epub 2019 Mar 23.

PMID:
31155055
19.

Tobacco industry promotions and pricing after tax increases: An analysis of internal industry documents.

Apollonio DE, Glantz SA.

Nicotine Tob Res. 2019 May 6. pii: ntz068. doi: 10.1093/ntr/ntz068. [Epub ahead of print]

PMID:
31058282
20.
21.

Exposure to household tobacco smoke and risk of cancer morbidity and mortality: Analysis of data from the Afghanistan Demographic and Health Survey 2015.

Bhatta DN, Hiatt RA, Van Loon K, Glantz SA.

Prev Med. 2019 Jun;123:217-224. doi: 10.1016/j.ypmed.2019.03.044. Epub 2019 Mar 30.

PMID:
30940572
22.

Electronic Cigarette Use and Smoking Initiation in Taiwan: Evidence from the First Prospective Study in Asia.

Chien YN, Gao W, Sanna M, Chen PL, Chen YH, Glantz S, Chiou HY.

Int J Environ Res Public Health. 2019 Mar 30;16(7). pii: E1145. doi: 10.3390/ijerph16071145.

23.

The Evidence of Electronic Cigarette Risks Is Catching Up With Public Perception.

Glantz SA.

JAMA Netw Open. 2019 Mar 1;2(3):e191032. doi: 10.1001/jamanetworkopen.2019.1032. No abstract available.

PMID:
30924882
24.

The Association Between E-cigarette Use and Myocardial Infarction Is What One Would Expect Based on the Biological and Clinical Evidence.

Alzahrani T, Glantz SA.

Am J Prev Med. 2019 Apr;56(4):627. doi: 10.1016/j.amepre.2018.11.006. No abstract available.

PMID:
30898224
25.

Optically inducible membrane recruitment and signaling systems.

Hannanta-Anan P, Glantz ST, Chow BY.

Curr Opin Struct Biol. 2019 Aug;57:84-92. doi: 10.1016/j.sbi.2019.01.017. Epub 2019 Mar 16. Review.

PMID:
30884362
26.

Tobacco industry involvement in children's sugary drinks market.

Nguyen KH, Glantz SA, Palmer CN, Schmidt LA.

BMJ. 2019 Mar 14;364:l736. doi: 10.1136/bmj.l736. No abstract available.

27.

Corrigendum to "Similar softening across different racial and ethnic groups of smokers in California as smoking prevalence declined" [Prev. Med. 120 (2019) 144-149].

Kulik MC, Glantz SA.

Prev Med. 2019 Jun;123:343. doi: 10.1016/j.ypmed.2019.02.008. Epub 2019 Feb 15. No abstract available.

PMID:
30773313
28.

Estimating the long-run relationship between state cigarette taxes and county life expectancy.

Baum A, Aguilar-Gomez S, Lightwood J, Bruzelius E, Glantz SA, Basu S.

Tob Control. 2020 Jan;29(1):81-88. doi: 10.1136/tobaccocontrol-2018-054686. Epub 2019 Jan 31.

PMID:
30705247
29.

Similar softening across different racial and ethnic groups of smokers in California as smoking prevalence declined.

Kulik MC, Glantz SA.

Prev Med. 2019 Mar;120:144-149. doi: 10.1016/j.ypmed.2019.01.020. Epub 2019 Jan 29. Erratum in: Prev Med. 2019 Feb 15;:.

PMID:
30703378
30.

Conflict of Interest Provisions in State Laws Governing Medical and Adult Use Cannabis.

Bowling CM, Glantz SA.

Am J Public Health. 2019 Mar;109(3):423-426. doi: 10.2105/AJPH.2018.304862. Epub 2019 Jan 24.

PMID:
30676801
31.

Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies.

Crosbie E, Bialous S, Glantz SA.

Tob Control. 2019 Dec;28(e2):e110-e118. doi: 10.1136/tobaccocontrol-2018-054668. Epub 2019 Jan 18.

PMID:
30659106
32.

E-cigarettes: Stick to the Evidence.

Alzahrani T, Pena I, Temesgen N, Glantz SA.

Am J Prev Med. 2019 Jan;56(1):160-161. doi: 10.1016/j.amepre.2018.09.004. No abstract available.

PMID:
30573144
33.

Scientific Quality of Health-Related Articles in Specialty Cannabis and General Newspapers in San Francisco.

Halvorson RT, Stewart CC, Thakur A, Glantz SA.

J Health Commun. 2018;23(12):993-998. doi: 10.1080/10810730.2018.1534906. Epub 2018 Oct 25.

34.

Heated tobacco products: the example of IQOS.

Glantz SA.

Tob Control. 2018 Nov;27(Suppl 1):s1-s6. doi: 10.1136/tobaccocontrol-2018-054601. No abstract available.

35.

San Francisco Voters End the Sale of Flavored Tobacco Products Despite Strong Industry Opposition.

Yang YT, Glantz S.

Ann Intern Med. 2018 Nov 20;169(10):708-709. doi: 10.7326/M18-2317. Epub 2018 Oct 9. No abstract available.

36.

Heated tobacco product regulation under US law and the FCTC.

Lempert LK, Glantz SA.

Tob Control. 2018 Nov;27(Suppl 1):s118-s125. doi: 10.1136/tobaccocontrol-2018-054560. Epub 2018 Oct 5.

37.

Limited implementation of the framework convention on tobacco control's tobacco tax provision: global comparison.

Hiilamo H, Glantz S.

BMJ Open. 2018 Oct 2;8(10):e021340. doi: 10.1136/bmjopen-2017-021340.

38.

Parental tobacco use and child death: analysis of data from demographic and health surveys from South and South East Asian countries.

Bhatta DN, Glantz S.

Int J Epidemiol. 2019 Feb 1;48(1):199-206. doi: 10.1093/ije/dyy209.

PMID:
30277524
39.

Authors' Response.

van der Eijk Y, Bialous S, Glantz SA.

Pediatrics. 2018 Oct;142(4). pii: e20181783B. doi: 10.1542/peds.2018-1783B. No abstract available.

40.

Light and mild redux: heated tobacco products' reduced exposure claims are likely to be misunderstood as reduced risk claims.

Popova L, Lempert LK, Glantz SA.

Tob Control. 2018 Nov;27(Suppl 1):s87-s95. doi: 10.1136/tobaccocontrol-2018-054324. Epub 2018 Sep 12.

41.

Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control.

Bialous SA, Glantz SA.

Tob Control. 2018 Nov;27(Suppl 1):s111-s117. doi: 10.1136/tobaccocontrol-2018-054340. Epub 2018 Sep 12.

42.

Association Between Electronic Cigarette Use and Myocardial Infarction.

Alzahrani T, Pena I, Temesgen N, Glantz SA.

Am J Prev Med. 2018 Oct;55(4):455-461. doi: 10.1016/j.amepre.2018.05.004. Epub 2018 Aug 22. Erratum in: Am J Prev Med. 2019 Oct;57(4):579-584.

43.

PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes.

Glantz SA.

Tob Control. 2018 Nov;27(Suppl 1):s9-s12. doi: 10.1136/tobaccocontrol-2018-054413. Epub 2018 Aug 21.

44.

Tobacco company strategies to identify and promote the benefits of nicotine.

Ling PM, Glantz SA.

Tob Control. 2019 May;28(3):289-296. doi: 10.1136/tobaccocontrol-2018-054300. Epub 2018 Aug 9.

PMID:
30093414
45.

Directly light-regulated binding of RGS-LOV photoreceptors to anionic membrane phospholipids.

Glantz ST, Berlew EE, Jaber Z, Schuster BS, Gardner KH, Chow BY.

Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7720-E7727. doi: 10.1073/pnas.1802832115. Epub 2018 Jul 31.

46.

Role of stakeholders in Nigeria's tobacco control journey after the FCTC: lessons for tobacco control advocacy in low-income and middle-income countries.

Egbe CO, Bialous SA, Glantz S.

Tob Control. 2019 Jul;28(4):386-393. doi: 10.1136/tobaccocontrol-2018-054344. Epub 2018 Jul 25.

PMID:
30045974
47.

Marketing with tobacco pack onserts: a qualitative analysis of tobacco industry documents.

Apollonio DE, Glantz SA.

Tob Control. 2019 May;28(3):274-281. doi: 10.1136/tobaccocontrol-2018-054279. Epub 2018 Jun 28.

48.

Marijuana Regulatory Frameworks in Four US States: An Analysis Against a Public Health Standard.

Barry RA, Glantz SA.

Am J Public Health. 2018 Jul;108(7):914-923. doi: 10.2105/AJPH.2018.304401.

49.

Noncigarette Tobacco Products-Gateway or Diversion?-Reply.

Watkins SL, Glantz SA, Chaffee BW.

JAMA Pediatr. 2018 Aug 1;172(8):784-785. doi: 10.1001/jamapediatrics.2018.1076. No abstract available.

PMID:
29868756
50.

The sugar industry's influence on policy.

Kearns C, Schmidt L, Apollonio D, Glantz S.

Science. 2018 May 4;360(6388):501. doi: 10.1126/science.aat3763. No abstract available.

PMID:
29724946

Supplemental Content

Loading ...
Support Center